SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930661-01-500367
Filing Date
2001-05-01
Accepted
2001-05-01 00:00:00
Documents
1
Group Members
BAY CITY CAPITAL FUND I, LLPBAY CITY CAPITAL LLCBAY CITY CAPITAL MANAGEMENT LLCBCC ACQUISITION III LLCNANA MANAGEMENT, LPNORTH AMERICAN NUTRITION & AGRIBUSINESS FUND, LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G - AXYS PHARMACEUTICALS INC. dsc13g.txt SC 13G 35576
  Complete submission text file 0000930661-01-500367.txt   38039
Mailing Address 180 KIMBALL WAY SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SOUTH SAN FRANCISCO CA 94080 6508291000
AXYS PHARMACEUTICALS INC (Subject) CIK: 0000913056 (see all company filings)

IRS No.: 222969941 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44967 | Film No.: 1619203
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 BATTERY STREET SUITE 600 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET SUITE 600 SAN FRANCISCO CA 94111 4156763830
BAY CITY CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001045170 (see all company filings)

IRS No.: 943272853 | State of Incorp.: DE | Fiscal Year End: 1231